Selective alpha 2B/2C agonists

Details for Australian Patent Application No. 2010276648 (hide)

Owner Allergan, Inc.

Inventors Nguyen, Phong X.; Chow, Ken; Heidelbaugh, Todd M.; Gomez, Dario G.; Fang, Wenkui K.; Sinha, Santosh C.; Garst, Michael E.; Gil, Daniel W.

Agent Davies Collison Cave

Pub. Number AU-A-2010276648

PCT Pub. Number WO2011/014332

Priority 61/229,910 30.07.09 US

Filing date 1 July 2010

Wipo publication date 3 February 2011

International Classifications

C07D 263/28 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 27/00 (2006.01) Drugs for disorders of the senses

C07D 277/18 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014332 Priority application(s): WO2011/014332

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010276650-Continuous positive airway pressure device and method

2010276646-Ultra high barrier aseptic film and package